Loading provider…
Loading provider…
Hematology & Oncology Physician in Atlanta, GA
NPI: 1174787352Primary Practice Location
GRADY MEMORIAL HOSPITAL
80 Jesse Hill Jr Dr Se, Atlanta, GA
Primary Employer
Emory Medical Care Foundation
emoryhealthcare.org
HQ Phone
Get M.D. Fuad's Phone NumberMobile
Get M.D. Fuad's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
GA State Medical License
2013 - 2027
MO State Medical License
2008 - 2011

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
SSM Health/Saint Louis University School of Medicine
Residency • Internal Medicine
2008 - 2011
American University of Beirut Faculty of Medicine
Medical School
Until 2006
Emory School of Medicine
med.emory.edu
Fellowship • Hematology and Medical Oncology
2011 - 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 19 | 44 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 14 | 20 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 14 | 24 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 11 | 20 |
Authors: Marcus Carden, Andres Chang, Satheesh Chonat, Ross Fasano
Journal: Transfusion
Publication Date: 2019-03-08
Authors: Kong, Jee Hyun, Winton, Elliott F, Heffner, Leonard T, Chen, Zhengjia, Langston, Amelia A, Hill, Brittany, Arellano, Martha, El-Rassi, Fuad, Kim, Audrey, Jillella, Anand, Kota, Vamsi K, Bodó, Imre, Khoury, Hanna Jean
Journal: Cancer
Publication Date: 2017-02-27
Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
Authors: Fuad El Rassi, Hanna Jean Khoury
Publication Date: 2013-08
Lead Sponsor: Afimmune
Intervention / Treatment: DRUG: Epeleuton
Lead Sponsor: Pfizer
Intervention / Treatment: DRUG: Osivelotor
Lead Sponsor: Forma Therapeutics, Inc.
Collaborators: Novo Nordisk A/S
Intervention / Treatment: DRUG: Etavopivat Tablets, DRUG: Etavopivat Tablets Low dose, DRUG: Etavopivat Tablets High dose, DRUG: Placebo Tablets